StockData
Alvotech logo

Alvotech (ALVO) income statement

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.29−0.26 (-5.71%)

Close on Nov 19, 2026Market cap $1.34BP/E 42.9Yield –

Alvotech income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
59.8%
Operating margin
13.3%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
1.65
Debt to equity
–
Debt to assets
82.3%
Cash to current liabilities
43.1%

Valuation

P/E ratio
42.9
Price to sales
2.28
Price to book
–
Dividend yield
–

See a number that looks wrong?